Showing results (371-380 of 381) with videos related to
Sort By:
Pageof 39
Neurology|February 1, 1987
Vigabatrin for refractory complex partial seizures: multicenter single-blind study with long-term follow-upT R Browne, R H Mattson, J K Penry, et al.Nature Genetics|July 1, 1996
Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathyS Reddy, D B Smith, M M Rich, et al.Gastrointestinal Endoscopy|June 1, 1997
Device choice and experience level in endoscopic foreign object retrieval: an in vivo studyD O Faigel, B R Stotland, M L Kochman, et al.The New England Journal of Medicine|July 18, 1985
Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizuresR H Mattson, J A Cramer, J F Collins, et al.The Journal of General Virology|July 28, 1999
Sequence diversity of TT virus in geographically dispersed human populationsL E Prescott, D M MacDonald, F Davidson, et al.International Journal of Sports Medicine|May 14, 2016
Electromyographic Responses from the Vastus Medialis during Isometric Muscle ActionsC M Smith, T J Housh, T Herda, et al.The Journal of Clinical Investigation|December 12, 2018
l-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humansRobert A Koeth, Betzabe Rachel Lam-Galvez, Jennifer Kirsop, et al.JAMA|April 3, 1999
Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke AssociationP B Gorelick, R L Sacco, D B Smith, et al.Journal of Medicinal Chemistry|October 11, 1996
Structure-activity relationships for inhibition of inosine monophosphate dehydrogenase by nuclear variants of mycophenolic acidP H Nelson, S F Carr, B H Devens, et al.Nature Medicine|August 8, 2018
Development of a gut microbe-targeted nonlethal therapeutic to inhibit thrombosis potentialAdam B Roberts, Xiaodong Gu, Jennifer A Buffa, et al.Pageof 39